Kim JJ - Search Results

1

An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.

Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. Levin CE, et al. Among authors: kim jj. Vaccine. 2015 Jun 4;33(24):2830-41. doi: 10.1016/j.vaccine.2015.02.052. Epub 2015 Mar 12. Vaccine. 2015. PMID: 25770785 Free article.

2

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.

Kim JJ, Wright TC, Goldie SJ. Kim JJ, et al. JAMA. 2002 May 8;287(18):2382-90. doi: 10.1001/jama.287.18.2382. JAMA. 2002. PMID: 11988059

3

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

Goldie SJ, Kim JJ, Wright TC. Goldie SJ, et al. Among authors: kim jj. Obstet Gynecol. 2004 Apr;103(4):619-31. doi: 10.1097/01.AOG.0000120143.50098.c7. Obstet Gynecol. 2004. PMID: 15051550

4

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

Kim JJ, Leung GM, Woo PP, Goldie SJ. Kim JJ, et al. J Public Health (Oxf). 2004 Jun;26(2):130-7. doi: 10.1093/pubmed/fdh138. J Public Health (Oxf). 2004. PMID: 15284314

5

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

Kim JJ, Wright TC, Goldie SJ. Kim JJ, et al. J Natl Cancer Inst. 2005 Jun 15;97(12):888-95. doi: 10.1093/jnci/dji162. J Natl Cancer Inst. 2005. PMID: 15956650

6

Chapter 19: Cost-effectiveness of cervical cancer screening.

Goldie SJ, Kim JJ, Myers E. Goldie SJ, et al. Among authors: kim jj. Vaccine. 2006 Aug 31;24 Suppl 3:S3/164-70. doi: 10.1016/j.vaccine.2006.05.114. Epub 2006 Jun 22. Vaccine. 2006. PMID: 16950004 Review.

7

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes.

Garnett GP, Kim JJ, French K, Goldie SJ. Garnett GP, et al. Among authors: kim jj. Vaccine. 2006 Aug 31;24 Suppl 3:S3/178-86. doi: 10.1016/j.vaccine.2006.05.116. Vaccine. 2006. PMID: 16950005 Review.

8

Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer.

Kwon JS, Carey MS, Goldie SJ, Kim JJ. Kwon JS, et al. Among authors: kim jj. J Obstet Gynaecol Can. 2007 Feb;29(2):131-139. doi: 10.1016/S1701-2163(16)32387-8. J Obstet Gynaecol Can. 2007. PMID: 17346483

9

Multiparameter calibration of a natural history model of cervical cancer.

Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Kim JJ, et al. Am J Epidemiol. 2007 Jul 15;166(2):137-50. doi: 10.1093/aje/kwm086. Epub 2007 May 25. Am J Epidemiol. 2007. PMID: 17526866

10

Cost-effectiveness of HPV 16, 18 vaccination in Brazil.

Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Goldie SJ, et al. Among authors: kim jj. Vaccine. 2007 Aug 14;25(33):6257-70. doi: 10.1016/j.vaccine.2007.05.058. Epub 2007 Jun 15. Vaccine. 2007. PMID: 17606315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,429 results

Search Page

Filters